You haven't searched anything yet.
Open date: March 22, 2023
Most recent review date: Monday, Mar 11, 2024 at 11:59pm (Pacific Time) Applications received after this date will be reviewed by the search committee if the position has not yet been filled.
Final date: Sunday, Sep 22, 2024 at 11:59pm (Pacific Time)
Applications will continue to be accepted until this date, but those received after the review date will only be considered if the position has not yet been filled.
Junior Specialist- Wilder Lab
Nature Of Research
The research laboratory of Dr. Catera Wilder in the Department of Bioengineering and Therapeutic Sciences of the University of California, San Francisco (UCSF) is engaged in groundbreaking projects focused on understanding the complex signaling and gene regulation of immune defense and pro-inflammatory responses during respiratory illnesses.
Epithelium at mucosal layers, such as in the respiratory tract, are primary targets during infections due to their role as barrier cells to the environment and thus have various host defense mechanisms. The innate immune functions of lung epithelial cells and their role controlling immune cell infiltration and inflammation, an important immune response that needs to be tightly controlled to prevent immune-mediated pathogenesis, needs to be fully understood. Thus, the molecular mechanisms of innate immune cellular signaling pathways and transcriptional regulation and their impact on immune cell recruitment and activation should be investigated.
The lab is seeking to recruit a Junior Specialist with expertise in the theory of and analytic methods of biology, molecular biology, biochemistry, microbiology, or a related field with experience in gene editing, next generation sequencing and bioinformatic analysis. The hire needs to have a passion about scientific research with the willingness and ability to learn, take risks, and work well with others.
The vision of the Wilder Lab is to mechanistically understand antiviral and inflammatory responses in the contexts of both health and inflammatory disease by understanding how lung epithelial cells control antiviral and inflammatory responses. This knowledge will be used to develop predictive, quantitative models of immune responses and develop cellular model systems that promote anti-viral immune responses.
Outline Of Responsibilities
Qualifications
Terms Of Appointment
Two year appointment. Reappointment is contingent on availability of funding and a positive review of the hire.
Please apply online athttps://aprecruit.ucsf.edu/JPF04455, with a CV, cover letter, and three references.
See Table 24B (https://www.ucop.edu/academic-personnel-programs/_files/2022-23/july-2022-salary-scales/t24-b.pdf) for the salary range for this position. A reasonable estimate for this position is $49,000 - $52,200.
Curriculum Vitae - CV must clearly list current and/or pending qualifications (e.g. board eligibility/certification, medical licensure, etc.).
Cover Letter
Statement of Research (Optional)
Statement of Teaching (Optional)
Statement of Contributions to Diversity - Please see the following page for more details: https://diversity.ucsf.edu/contributions-to-diversity-statement
(Optional)
Misc / Additional (Optional)
As a University employee, you will be required to comply with all applicable University policies and/or collective bargaining agreements, as may be amended from time to time. Federal, state, or local government directives may impose additional requirements.
UC San Francisco seeks candidates whose experience, teaching, research, or community service has prepared them to contribute to our commitment to diversity and excellence. The University of California is an Equal Opportunity/Affirmative Action Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, age or protected veteran status.
Full Time
Transportation
$95k-119k (estimate)
03/29/2024
05/28/2024
ucsf.edu
SAN FRANCISCO, CA
15,000 - 50,000
1873
DAESUNG SHIA
$10B - $50B
Transportation